FoCo: Evaluating a Training to Increase Attention and Awareness of Healthcare Professionals (FoCo)

February 10, 2021 updated by: Hospital Israelita Albert Einstein

Foco: Evaluating a Training to Increase Attention and Awareness in the Daily Activities of Healthcare Professionals

Introduction: A significant increase in the risk of injury and illness at work has been associated with fatigue, stress, haste, distraction, emergency situations, excessive noise, complex procedures and anger among other factors.

Most of these factors are related to the lack of attention to work in progress, which can be improved by training attention and awareness during daily activities, as it would encourage a resumption of focus on the task at hand and the possible risks associated with it. . The primary objective of this project is to evaluate the effects of training to increase attention and awareness for daily activities - FoCo - outlined for healthcare professionals in their work schedule. Method: Health professionals from 18 to 60 years of age, of both sexes, will participate in the study, working in 3 units, one in the care of patients in a Emergency Care Unit (UPA), in an Elderly Residential and in a Center. Intensive Care (ICU). In the UPA will be included 25 professionals in group A and 25 in group B; In the Residential of Elderly, 40 professionals will be included in group A and 40 professionals in group B; In the ICU will be included 30 professionals in group A and 30 in group B. They will be randomized in both groups. Group A will receive training in the FoCo program and group B will be a waiting group. After a period of one month, group B will receive training in FoCo and group A will be instructed to continue on their own to apply FoCo in their daily lives (Fig.1). Participants will be evaluated before, after one month and after two months. Expected Outcomes: After training, an increase in mindful, attention and awareness scale, self-compassion scale, positive affect, speed of digit and symbol test is expected. It is also expected to reduce negative affects, perceived stress and an increased perception of possible incidents.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

190

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sao Paulo, Brazil, 05652901
        • Hospital Israelita Albert Einstein

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • be available to participate in the training and to perform the evaluations before and after it.

Exclusion Criteria:

- being away or on vacation during the research project, being in psychiatric treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A (first group to receive the intervention)
This arm will receive the attention, care, and self-care training first.
This is an attention, care and self-care training.
This is a waiting list
Experimental: B (second group to receive the intervention)
This arm will not receive intervention in the first month and will receive it after this period.
This is an attention, care and self-care training.
This is a waiting list

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in stress
Time Frame: 1 month
The authors will evaluate attention using the MAAS (Mindful Attention Awareness Scale).
1 month
change in attention
Time Frame: 1 month
The authors will apply the Perceived Stress Scale
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in self-compassion
Time Frame: 1 month
The authorswill apply the self-compassion scale
1 month
change in sleep
Time Frame: 1 month
The authors will apply the Pittsburgh inventory
1 month
change in Mental health symptoms
Time Frame: 1 month
The authors will apply the SRQ-20 (self-report questionnaire)
1 month
change in positive and negative affect
Time Frame: 1 month
The authors will apply PANAS
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elisa H Kozasa, PhD, Hospital Israelita Albert Einstein

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 20, 2019

Primary Completion (Actual)

May 20, 2020

Study Completion (Actual)

December 20, 2020

Study Registration Dates

First Submitted

December 19, 2019

First Submitted That Met QC Criteria

April 22, 2020

First Posted (Actual)

April 24, 2020

Study Record Updates

Last Update Posted (Actual)

February 11, 2021

Last Update Submitted That Met QC Criteria

February 10, 2021

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • HIAE_FoCo

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention

Subscribe